-
Shares of Kiniksa Pharmaceuticals, Ltd.
KNSA
surged 18.3% after the company reported that Phase 2 trial of mavrilimumab in giant cell arteritis had achieved both the primary and secondary efficacy endpoints with statistical significance
-
Gamida Cell Ltd.’s
GMDA
shares jumped 9.5% after the company announced that its Phase 3 clinical study of Omidubicel met all three of its secondary endpoints.
-
Shares of BioNTech SE
BNTX
rose 6.1% after the company and Pfizer reported the initiation of rolling submission to the EMA for SARS-CoV-2 vaccine candidate BNT162b2.
-
Naked Brand Group Limited’s
NAKD
shares jumped 5.7% after the company announced that its subsidiary, Bendon, has entered into a settlement deal with Timothy Connell, William Gibson and Ivory Castle.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
